Continuous Renal Replacement Therapy: Forty-year Anniversary
Author:
Open Access
- 31 May 2017
- journal article
- review article
- Published by SAGE Publications in The International Journal of Artificial Organs
- Vol. 40 (6) , 257-264
Abstract
In 1977 Peter Kramer performed the first CAVH (continuous arteriovenous hemofiltration) treatment in Gottingen, Germany. CAVH soon became a reliable alternative to hemo- or peritoneal dialysis in critically ill patients. The limitations of CAVH spurred new research and the discovery of new treatments such as CVVH and CVVHD (continuous veno-venous hemofiltration and continuous veno-venous hemodialysis). The alliance with industry led to development of new specialized equipment with improved accuracy and performance in delivering continuous renal replacement therapies (CRRTs). Machines and filters have progressively undergone a series of technological steps, reaching a high level of sophistication. The evolution of technology has continued, leading to the development and clinical application of new membranes, new techniques and new treatment modalities. With the progress of technology, the entire field of critical care nephrology moved forward, expanding the areas of application of extracorporeal therapies to cardiac, liver and pulmonary support. A great deal of research made extracorporeal therapies an interesting option for the treatment of sepsis and intoxication and the additional use of sorbents was explored. With the progress in understanding the pathophysiology of acute kidney injury (AKI), new guidelines were developed, driving indications, modalities of prescription, monitoring techniques and quality assurance programs. Information technology and precision medicine have recently contributed to further evolution of CRRT, with the possibility of collecting data in large databases and evaluating policies and practice patterns. This is likely to ultimately result in improved patient care. CRRTs are 40 years old today, but they are still young and full of potential for further evolution.Keywords
This publication has 86 references indexed in Scilit:
- Leukocyte capture and modulation of cell-mediated immunity during human sepsis: an ex vivo studyCritical Care, 2013
- Technical Advances in Renal Replacement TherapySeminars in Dialysis, 2011
- Protective effect of resin adsorption on septic plasma-induced tubular injuryCritical Care, 2010
- Delivered dose of renal replacement therapy and mortality in critically ill patients with acute kidney injuryCritical Care, 2009
- Dialysis dose in acute kidney injury: no time for therapeutic nihilism – a critical appraisal of the Acute Renal Failure Trial Network studyCritical Care, 2008
- Dose of Dialysis in Acute Renal FailureClinical Journal of the American Society of Nephrology, 2006
- Effect of fluid overload and dose of replacement fluid on survival in hemofiltrationPediatric Nephrology, 2004
- High-Volume Hemofiltration in SepsisNephron, 2002
- Pharmacokinetic principles during continuous renal replacement therapy: Drugs and dosageKidney International, 1999
- Five years experience with continuous extracorporeal renal support in paediatric intensive careIntensive Care Medicine, 1991